13 November - 17 December 2023 17:00 PM CET
WHO is seeking comments and feedback from Member States and other stakeholders on the below consultation document, “WHO strategic and operational priorities to address drug-resistant bacterial infections, 2025-2035,” ahead of the 154th meeting of WHO’s Executive Board in January 2024.
Pursuant to the requests at the Seventy-sixth World Health Assembly for substantive discussions, in line with resolution WHA72.5 (2019) and in preparation for the high-level meeting of the United Nations General Assembly on antimicrobial resistance, scheduled to be held in September 2024, the WHO Director-General will submit a similar document as a report to the Executive Board. Feedback from the global consultation will be referred to during Executive Board discussions.